...
首页> 外文期刊>Journal of pharmacological sciences. >Losartan normalizes endothelium-derived hyperpolarizing factor-mediated relaxation by activating Ca2+ -activated K+ channels in mesenteric artery from type 2 diabetic GK rat
【24h】

Losartan normalizes endothelium-derived hyperpolarizing factor-mediated relaxation by activating Ca2+ -activated K+ channels in mesenteric artery from type 2 diabetic GK rat

机译:氯沙坦通过激活2型糖尿病GK大鼠肠系膜动脉中的Ca2 +激活的K +通道来正常化内皮源的超极化因子介导的舒张

获取原文
获取原文并翻译 | 示例
           

摘要

Ca2+ -activated K+ (K Ca) channels are important for endothelium-derived hyperpolarizing factor (EDHF) signaling. Since treatment with angiotensin II receptor blockers (ARBs) improves vasculopathies in type 2 diabetic patients, we asked whether the EDHF-type relaxation and its associated KCa channels [small (SKCa)-, intermediate (IKCa)-, and large (BKCa)-conductance channels] are abnormal in mesenteric arteries isolated from Goto-Kakizaki (GK) rats at the chronic stage of type 2 diabetes (34 - 38 weeks) and whether an ARBs (losartan, 25 mg · kg-1 · day-1 for 2 weeks) might correct these abnormalities. Although the acetylcholine chloride-induced EDHF-type relaxation in mesenteric arteries from GK rats was reduced versus the Wistar controls, it was significantly restored by losartan treatment. The SK Ca -blocker apamin or the IKCa -blocker 1-[(2-chlorophenyl)diphenylmethyl]-1 H -pyrazole (TRAM-34) inhibited such relaxations in the losartan-treated or -untreated Wistar groups and in the losartan-treated GK group, but not in the losartan-untreated GK group. The BKCa -blocker iberiotoxin had a significant inhibitory effect in only one of these groups, the losartan-treated GK. The relaxations induced by the SKCa /IKCa acti-vator NS309 and the BKCa activator NS1619, which were impaired in GK rats, were normalized by losartan treatment. We conclude that losartan improves EDHF-type relaxation in GK rats at least partly by normalizing SKCa/IKCaactivities and increasing BKCa activity.
机译:Ca2 +激活的K +(K Ca)通道对于内皮衍生的超极化因子(EDHF)信号很重要。由于使用血管紧张素II受体阻滞剂(ARBs)的治疗可改善2型糖尿病患者的血管病变,因此我们询问EDHF型弛豫及其相关的KCa通道[小(SKCa)-,中级(IKCa)-和大(BKCa)-电导通道]在2型糖尿病慢性期(34-38周)从五岛崎崎(GK)大鼠分离的肠系膜动脉中异常,并且是否存在ARB(氯沙坦,25 mg·kg-1·第1天2个星期)可能会纠正这些异常情况。尽管与Wistar对照相比,GK大鼠肠系膜动脉中乙酰胆碱氯化物诱导的EDHF型松弛减少,但氯沙坦治疗可明显恢复。 SK Ca受体阻滞剂apamin或IKCa受体阻滞剂1-[((2-氯苯基)二苯基甲基] -1 H-吡唑(TRAM-34)在经氯沙坦治疗或未经治疗的Wistar组和经氯沙坦治疗的Wistar组中均抑制了这种松弛GK组,但未经氯沙坦治疗的GK组除外。 BKCa阻滞剂纤毛毒素仅在氯沙坦治疗的GK这一组中具有显着的抑制作用。通过氯沙坦治疗使在GK大鼠中受损的SKCa / IKCa激活剂NS309和BKCa激活剂NS1619诱导的松弛作用正常化。我们得出的结论是,氯沙坦至少可以通过使SKCa / IKCa活性正常化并增加BKCa活性来改善GK大鼠的EDHF型松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号